Icardio.AI

AI echo analysis, in a heartbeat.

Icardio.AI is a healthcare company in Los Angeles, United States, founded in 2023. It has raised $5.6M across 3 rounds, most recently a $4.5M Corporate Round in 2025 (est.).

Employees
11–50
Founded
2023
Business Model
B2B
Website
icardio.ai
Total Funding
$5.6M
Last Round
$4.5M Corporate RoundJan 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. to use credits for reveals, or explore the API.

About

iCardio.ai develops AI for ultrasound imaging interpretation with a focus on echocardiograms. Built on a proprietary dataset of over 200M annotated ultrasound images, the platform serves leading ultrasound hardware and software companies including GE Healthcare. Their FDA-cleared CardioVision™ product automates aortic stenosis detection from standard echo and handheld devices.

Funding History

Data from Indexed.vcUpdated
Corporate RoundCorporate Round2025 (est.)
$4.5M

2 more funding events

  • Corporate Round2024
  • Seed20232 investors

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1
  • Frontend ×1
  • Marketing & SEO ×1
  • Other ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Icardio.AI on Indexed.vc
<a href="https://indexed.vc/companies/icardioai"><img src="https://indexed.vc/api/badge/company/icardioai" alt="Icardio.AI on Indexed.vc" width="260" height="76" /></a>